Immunogenicity of Recombinant Proteins Consisting of Plasmodium vivax Circumsporozoite Protein Allelic Variant-Derived Epitopes Fused with Salmonella enterica Serovar Typhimurium Flagellin

A Plasmodium falciparum circumsporozoite protein (CSP)-based recombinant fusion vaccine is the first malaria vaccine to reach phase III clinical trials. Resistance to infection correlated with the production of antibodies to the immunodominant central repeat region of the CSP. In contrast to P. falc...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Leal, Monica Teixeira Andrade, Camacho, Ariane Guglielmi Ariza, Teixeira, Laís Helena, Bargieri, Daniel Youssef, Soares, Irene Silva, Tararam, Cibele Aparecida, Rodrigues, Mauricio M.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2013
Témata:
Vaccines
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3889588/
https://ncbi.nlm.nih.gov/pubmed/23863502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00312-13
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky